The Parallels Between Chance and Point in Dual Anti-Platelet Therapy

Based on this study we're suggesting that dual anti-platelet therapy with aspirin and clopidogrel is not inferior to systemic trombolysis with IV altiplays according to the standard protocol. This was a study conducted purely in China so of course the question of how transportable are these data outside of China is another big question. The fact that there are some similarities in outcomes between chance and point I think you can potentially speculate that that might be the case for these patientsbetween DAP and intravenous altiplays.